PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CD14 9,941 Target Disease Bursitis 2,133 2 0.00 -1.00 0.00 0.56
CD14 9,941 Target Target CD95 4,266 33 0.01 -0.99 0.01 0.64
CD14 9,941 Target Target Arachidonate 5-Lipoxygenase 170 1 0.00 -1.00 0.01 0.59
CD14 9,941 Target Disease Retinitis 9,116 1 0.00 -1.00 0.00 0.50
CD14 9,941 Target Target CXCL9 1,016 16 0.01 -0.99 0.02 0.64
CD14 9,941 Target Disease HIV/AIDS 20,397 5 0.00 -1.00 0.00 0.53
CD14 9,941 Target Disease Neutropenia 25,934 19 0.00 -1.00 0.00 0.56
CD14 9,941 Target Disease Hepatitis 163,842 138 0.00 -0.99 0.01 0.57
CD14 9,941 Target Target Collagen 138,882 170 0.00 -0.99 0.02 0.58
CD14 9,941 Target Disease Keratitis 10,599 4 0.00 -1.00 0.00 0.54
CD14 9,941 Target Target EG-VEGF 63 1 0.00 -0.99 0.02 0.61
CD14 9,941 Target Disease Cholesterol 182,390 111 0.00 -0.99 0.01 0.55
CD14 9,941 Target Target Inosine-5'-Monophosphate Dehydrogenase 261 2 0.00 -1.00 0.01 0.60
CD14 9,941 Target Target bFGF 9,327 10 0.00 -1.00 0.00 0.57
Erbb2 4,536 Target Disease Diarrhea 51,986 32 0.00 -1.00 0.01 0.57
AMY2B 21 Target Disease Scoliosis 14,102 1 0.00 -0.98 0.05 0.62
Des (1-3) IGF-I 191 Target Disease Benign Prostatic Hyperplasia 10,026 1 0.00 -1.00 0.01 0.59
Des (1-3) IGF-I 191 Target Target Des (1-6) IGF-II 18 5 0.09 -0.84 0.28 0.81
Des (1-3) IGF-I 191 Target Disease Renal Failure 73,993 4 0.00 -0.99 0.02 0.57
Des (1-3) IGF-I 191 Target Disease Hyperglycemia 28,168 2 0.00 -0.99 0.01 0.58
Des (1-3) IGF-I 191 Target Disease Prostate Cancer 71,064 1 0.00 -1.00 0.01 0.54
AMY2B 21 Target Target Pancreatic Alpha-Amylase 423 3 0.03 -0.92 0.14 0.76
AMY2B 21 Target Target AMY1A 13 2 0.12 -0.87 0.15 0.87
AMY2B 21 Target Disease Psoriasis 26,882 1 0.00 -0.98 0.05 0.60
AMY2B 21 Target Target Alpha-Amylase 7,171 9 0.02 -0.76 0.43 0.70
Des (1-3) IGF-I 191 Target Target BMP-7 1,112 1 0.00 -1.00 0.01 0.65
AMY2B 21 Target Target APOA2 118 1 0.02 -0.97 0.05 0.76
CD14 9,941 Target Target Cytokeratin 18 1,108 3 0.00 -1.00 0.00 0.58
CD14 9,941 Target Disease Urticaria 10,717 4 0.00 -1.00 0.00 0.54
CD14 9,941 Target Disease Mesothelioma 11,198 5 0.00 -1.00 0.00 0.54
CD14 9,941 Target Disease Glioblastoma 17,933 17 0.00 -1.00 0.00 0.57
CD14 9,941 Target Target Multidrug Resistance Protein 1 495 1 0.00 -1.00 0.00 0.57
CD14 9,941 Target Disease Osteomyelitis 17,273 5 0.00 -1.00 0.00 0.53
CD14 9,941 Target Disease Malnutrition 27,452 6 0.00 -1.00 0.00 0.52
Des (1-3) IGF-I 191 Target Target Dihydrofolate Reductase 5,563 1 0.00 -1.00 0.01 0.60
Des (1-3) IGF-I 191 Target Target Collagen 138,882 9 0.00 -0.98 0.05 0.58
CD14 9,941 Target Disease Infertility 35,448 13 0.00 -1.00 0.00 0.54
Erbb2 4,536 Target Target EPHA4 357 4 0.00 -0.99 0.01 0.64
Erbb2 4,536 Target Disease Hyperglycemia 28,168 2 0.00 -1.00 0.00 0.51
Erbb2 4,536 Target Disease Aggression 20,035 1 0.00 -1.00 0.00 0.50
Erbb2 4,536 Target Disease Dehydration 21,928 1 0.00 -1.00 0.00 0.50
Erbb2 4,536 Target Disease Skin Cancer 11,561 6 0.00 -1.00 0.00 0.57
Erbb2 4,536 Target Disease Brain Cancer 1,542 5 0.00 -1.00 0.00 0.62
Erbb2 4,536 Target Disease Chronic Obstructive Pulmonary Disease 27,780 2 0.00 -1.00 0.00 0.51
Erbb2 4,536 Target Disease Tuberculosis 146,217 1 0.00 -1.00 0.00 0.46
Erbb2 4,536 Target Disease Acute Promyelocytic Leukemia 4,780 2 0.00 -1.00 0.00 0.56
Erbb2 4,536 Target Disease Prostate Cancer 71,064 77 0.00 -0.99 0.02 0.59
Des (1-3) IGF-I 191 Target Target Platelet Activating Factor 9,915 1 0.00 -1.00 0.01 0.59
Des (1-3) IGF-I 191 Target Disease Inflammation 252,734 1 0.00 -1.00 0.01 0.51
Des (1-3) IGF-I 191 Target Disease Inflammatory Bowel Diseases 4,684 1 0.00 -1.00 0.01 0.61